024), whereas those of Snail and Twist were shown to correlate wi

024), whereas those of Snail and Twist were shown to correlate with neither Cox-2 nor CDH-1. Figure 1 CH5183284 research buy baseline mRNA expression of Cox-2, CDH-1 and its transcriptional repressors in HNSCC cells. The mRNA expression levels of each gene in the HNSCC cell lines were assessed by quantitative real-time PCR. The relative expression levels were normalized by dividing each value by that of SAS as a calibrator for convenience. A: Cox-2 and CDH-1. B: SIP1, Snail, and Twist. While a trend toward an inverse correlation was found between Cox-2 and CDH-1 (rs = −0.714, p = 0.055), SIP1 was shown to significantly correlate with Cox-2 (rs = 0.771, p = 0.042) and to inversely correlate with CDH-1 (rs = −0.886, p = 0.024) by Spearman rank correlation

Ro 61-8048 mw coefficient. Based on these baseline mRNA expression levels, we selected the following cells for the in vitro PSI-7977 experiments: HSC-2 expressing

a relatively high level of Cox-2 and a low level of CDH-1, and HSC-4 expressing a relatively low level of Cox-2 and a high level of CDH-1. Alterations in the mRNA expressions of CDH-1 and its transcriptional repressors by Cox-2 inhibition We examined the effect of Cox-2 inhibition on the mRNA expressions of CDH-1 and its transcriptional repressors in the cell lines HSC-2 and HSC-4, using the three selective Cox-2 inhibitors celecoxib, NS-398, and SC-791. As regards the dose and exposure time of Cox-2 inhibitor, because we observed neither time-dependent nor dose-dependent manner in the regulation with each Cox-2 inhibitor in our preliminary experiments,

the results were shown with the doses and exposure times considered to be optimal for each Cox-2 inhibitor and each purpose. In the HSC-2 cells, Cox-2 inhibition upregulated the CDH-1 expression compared to DMSO treatment as the control, increasing by 1.60-, 1.93-, and 1.20-fold with celecoxib, NS-398, and SC-791, respectively (Figure 2A). In contrast, Cox-2 inhibition in the HSC-4 cells resulted in relatively less upregulation of CDH-1 expression (Figure 2B). These results suggest that the extent of the effect of Rolziracetam Cox-2 inhibition may vary depending on the cell type and presumably on the baseline expression levels of both CDH-1 and Cox-2 in each cell. Figure 2 Alterations in the mRNA expression of CDH-1 and its transcriptional repressors by Cox-2 inhibition. The effect of Cox-2 inhibition on the mRNA expressions of CDH-1 and its transcriptional repressors (SIP1, Snail, and Twist) was examined by quantitative real-time PCR using three different selective Cox-2 inhibitors: celecoxib, NS-398, and SC-791. A: In HSC-2 cells, Cox-2 inhibition upregulated the CDH-1 expression compared to DMSO treatment as the control. B: In HSC-4 cells, Cox-2 inhibition resulted in relatively less upregulation of CDH-1 expression. C: In HSC-2 cells, all three transcriptional repressors were clearly downregulated by each of the Cox-2 inhibitors. D: In HSC-4 cells, Cox-2 inhibition led to relatively less downregulation of these transcriptional repressors.

Comments are closed.